Literature DB >> 7917790

Molecular cloning and functional characterization of a human liver vasoactive intestinal peptide receptor.

A W Gagnon1, N Aiyar, N A Elshourbagy.   

Abstract

We have isolated a cDNA from a human liver library which is 2349 base pairs in length and encodes a near-full length seven transmembrane receptor (432 amino acids), 85% homologous to the amino acid sequence for the rat vasoactive intestinal peptide (VIP) receptor. Northern blot analysis identifies a major species at 3.3 kb in lung, and to a lesser extent in brain, heart and liver. In order to confirm the identity of this human clone, double-stranded oligonucleotides encoding the signal peptide of the rat VIP receptor were constructed by polymerase chain reaction and attached to the 5' end of the human clone. COS cells transiently transfected with this human VIP receptor chimera, express a single binding site for 125I-VIP with a Kd of 9.2 +/- 2 nM. Related peptides displace 125I-VIP with a relative potency of VIP = PACAP > helodermin >> PHM > secretin, which is similar to the binding profile seen in human tissues. This human chimeric receptor is functionally coupled to the stimulation of adenylyl cyclase in transfected COS cells, as evidenced by a dose-dependent increase in intracellular cAMP accumulation. These studies indicate that this cDNA encodes a human liver VIP receptor which is functionally coupled to the activation of adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917790     DOI: 10.1016/0898-6568(94)90037-x

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  3 in total

1.  Protein kinase enzymes in the human vagina-relation to key mediators of the cyclic AMP and cyclic GMP pathways.

Authors:  S Ückert; J Sonnenberg; J E Sonnenberg; W Kauffels; K Albrecht; M A Kuczyk; P Hedlund
Journal:  Int J Impot Res       Date:  2017-04-13       Impact factor: 2.896

2.  Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.

Authors:  Gabriella Horvath; Reka Brubel; Krisztina Kovacs; Dora Reglodi; Balazs Opper; Andrea Ferencz; Peter Szakaly; Eszter Laszlo; Lidia Hau; Peter Kiss; Andrea Tamas; Boglarka Racz
Journal:  J Mol Neurosci       Date:  2010-07-30       Impact factor: 3.444

3.  Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

Authors:  Ventzislav Petkov; Wilhelm Mosgoeller; Rolf Ziesche; Markus Raderer; Leopold Stiebellehner; Karin Vonbank; Georg-Christian Funk; Gerhard Hamilton; Clemens Novotny; Bernhard Burian; Lutz-Henning Block
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.